Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04198766
Title Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Inhibrx Biosciences, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
Valkyrie Clinical Trials RECRUITING Los Angeles California 90069 United States Details
Winship Cancer Institute - Emory University RECRUITING Atlanta Georgia 30322 United States Details
The University of Chicago Medical Center RECRUITING Chicago Illinois 60637 United States Details
University of Iowa RECRUITING Iowa City Iowa 52242 United States Details
Norton Cancer Institute RECRUITING Louisville Kentucky 40202 United States Details
Henry Ford Cancer Institute RECRUITING Detroit Michigan 48202 United States Details
START Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
Nebraska Cancer Specialists RECRUITING Omaha Nebraska 68130 United States Details
Providence Portland Medical Center RECRUITING Portland Oregon 97213 United States Details
Vanderbilt University School of Medicine RECRUITING Nashville Tennessee 37204 United States Details
Renovatio Clinical - El Paso RECRUITING El Paso Texas 79915 United States Details
NEXT Oncology COMPLETED San Antonio Texas 78229 United States Details
Renovatio Clinical RECRUITING The Woodlands Texas 77380 United States Details
Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
Froedtert Hospital and the Medical College of Wisconsin RECRUITING Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field